Researchers suggest effective COVID-19 screening within hemodialysis centers needs to include both RT-PCR and antibody testing to identify all patients requiring isolation.
Patients with multiple myeloma on dialysis who are undergoing autologous stem cell transplantation are at an increased risk for inpatient mortality.
Increases in mortality for same day, over following 30 days linked to increase in PM2.5 exposure.
In separate COVID-19 studies, investigators found that only some infected kidney transplant outpatients required hospitalization and patients on maintenance hemodialysis often have an atypical presentation of symptoms.
In a study, nonattendance of a hemodialysis session was significantly associated with higher mortality compared with attendance: 51.9 vs 4.86 per 100 patient-years.
Dialysis decision regret less likely for those who discuss prognosis with doctors, complete living will.
In a study of dialysis patients with new-onset nonvalvular atrial fibrillation, investigators found a nearly 3-fold higher incidence of fatal or intracranial bleeding among patients who took apixaban compared with those who received no treatment.
In a study of dialysis patients in Taiwan, hemodialysis patients had a greater risk for acute myocardial infarction than peritoneal dialysis patients.
In an early case series from a New York hospital, nearly 31% of patients with end-stage kidney disease with COVID-19 died.
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.